Pulsenmore Expands U.S. Footprint with Maryland Maternal-Fetal Practice Deal

Event summary

  • Pulsenmore signed a services agreement with TLC Perinatal PA in Maryland for home ultrasound integration.
  • TLC Perinatal manages ~2,000 pregnancies annually across two locations.
  • The deal follows Pulsenmore's FDA clearance and marks its second U.S. commercial engagement.
  • Home ultrasounds will be part of a hybrid care model combining telehealth and in-clinic visits.
  • TLC Perinatal's Medical Director highlights alignment with ACOG's 2025 Clinical Consensus.

The big picture

This deal signals growing interest in home-based prenatal care solutions among U.S. maternal-fetal medicine practices. Pulsenmore's hybrid model addresses both patient convenience and clinician oversight, positioning it within broader telehealth expansion trends. The engagement with TLC Perinatal—recognized for technology integration—suggests potential for faster adoption among progressive practices.

What we're watching

Adoption Pace
How quickly Pulsenmore can secure additional U.S. practice partnerships following this deal.
Regulatory Alignment
Whether ACOG's 2025 Clinical Consensus will accelerate broader adoption of home ultrasound technologies.
Revenue Model
The sustainability of Pulsenmore's service-based revenue approach in the U.S. market.